2299 |
NOBORI in Bifurcation Lesion: Study Update from Japan |
Nobuhiro Tanaka |
May. 12. 14 |
2298 |
Update on Relationship Between Platelet Reactivity and Clinical Outcomes: How to Select Optimal Patients for Prasugrel? |
Young-Hoon Jeong |
May. 12. 14 |
2297 |
New AHA/ACC Guidelines : Why the Controversy? |
So-Yeon Choi |
May. 12. 14 |
2296 |
Shifting the Paradigm for Lipid Management: Pathways in Achieving Improved ASCVD Outcomes |
Duk-Woo Park |
May. 12. 14 |
2295 |
Advances in Atherothrombosis Management in the Complex Patients |
Jung-Sun Kim |
May. 12. 14 |
2294 |
Debate on Duration of Antiplatelet Therapy After PCI |
Joo-Yong Hahn |
May. 12. 14 |
2293 |
Review the Benefits and Limitations of Current Antiplatelet Therapy |
Seung-Jin Oh |
May. 12. 14 |
2292 |
Clinical Application of Functional SYNTAX Score |
Chang-Wook Nam |
May. 12. 14 |
2291 |
Assessment and Clinical Relevance of Coronary Microvasculature |
William F. Fearon |
May. 12. 14 |
2290 |
How to Physiologically Interpret IVUS Parameters? |
Soo-Jin Kang |
May. 12. 14 |